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The v itam in  K -dependent y-carboxylation o f g lu ta ­
m ate  to  y-carboxyglutam ate w as orig inally  w ell c h a ra c ­
te rized  in  th e  m am m alian  blood c lo tting  cascade. y-Car- 
boxyg lu tam ate h a s  also been  found in  a  n u m b er o f o th e r  
m am m alian  p ro te in s  an d  in  n eu ro p ep tid es  from  th e  v en ­
om s o f m arin e  sna ils  belong ing  to  th e  genus Conus, sug­
gesting  w id er p revalence  of y-carboxylation. We dem on­
s tra te  th a t  an  open  read in g  fram e from  a  D rosophila  
m elanogaster  cDNA clone encodes a  p ro te in  w ith  v ita ­
m in  K -dependent y-carboxylase activ ity . The open  re a d ­
in g  fram e, 670 am ino acids in  leng th , is tru n c a te d  a t  th e  
C -term inal end  com pared  w ith  m am m alian  y-carboxyl- 
ase, w hich  is 758 am ino acids. The m am m alian  gene h as  
14 in tro n s; in  D rosophila  th e re  a re  tw o m uch sh o rte r  
in tro n s  b u t in  positions prec ise ly  hom ologous to  tw o of 
th e  m am m alian  in tro n s . In  ad d ition , a  de le tion  of 6 n u ­
cleo tides is observed  w hen  cDNA an d  genom ic se ­
quences a re  com pared . In  s itu  h y b rid iza tio n  to  fixed 
em bryos in d ica ted  u b iq u ito u s p resence  o f carboxylase 
mRNA th ro u g h o u t em bryogenesis. N o rth e rn  b lo t an a ly ­
sis revea led  in c reased  mRNA levels in  12-24-h em bryos. 
The co n tin u ed  p resence  of carboxylase mRNA suggests 
th a t  it  p lays an  im p o rta n t ro le d u rin g  em bryogenesis. 
A lthough th e  m odel su b s tra te  FLEEL is carboxy la ted  by 
th e  enzym e, a  su b s tra te  co n ta in in g  th e  p ro p ep tid e  o f a 
Conus carboxylase  su b s tra te , co n an to k in  G, is  poorly 
carboxy lated . I ts  occu rrence  in  v e rteb ra tes , m olluscan  
system s (i.e. Conus), an d  D rosophila  an d  th e  ap p aren tly  
s tro n g  hom ology be tw een  th e  th re e  system s suggest th a t  
th is  is a  h igh ly  conserved  an d  w idely d is tr ib u te d  p o st­
tra n s la tio n a l m odification  in  bio logical system s.
The functions of proteins are coordinated physiologically by 
post-translational modification. For example, phosphorylation- 
dephosphorylation cascades integrate the biochemistry of indi­
vidual proteins into cellular physiology. In addition to post­
translational modifications that occur primarily within cells,
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post-translational modifications also occur on extracellular 
proteins. The most familiar of these are JV-glycosylation of 
asparagine residues and O-glycosylation of serine and threo­
nine residues.
One of the most distinctive of the extracellular post-transla­
tional modifications is the vitamin K-dependent -y-carboxyla- 
tion of glutamate residues to give -y-carboxyglutamate (l). 
When it was first characterized, -y-carboxylation was thought to 
be a biochemical specialization of the mammalian blood-clot­
ting cascade. However, several bone proteins ( 2, 3) as well as an 
extracellular ligand, gas6 (4), were subsequently identified as 
having the post-translational modification, although in the la t­
ter cases the precise mechanistic role of -y-carboxylation for 
proper protein function has not been established definitively. 
In addition, two novel proline-rich -y-carboxyglutamic acid-con­
taining proteins, PRGPl and PRGP2, of unknown function 
have been identified ( 5).
Long after its characterization in blood-clotting factors, vita­
min K-dependent -y-carboxylation of glutamate residues was 
discovered in a phylogenetic ally distant system: the neuropep­
tides made in the venom duct of the predatory cone snails 
Conus (6, 7). The venoms of these snails have -100  different 
peptides; —5% of these are believed to be -y-carboxylated ( 8). 
This post-translational modification has been found in a num­
ber of diverse Conus peptides but has been studied most inten­
sively in an unusual Conus neuropeptide family, the conan- 
tokins, which are NMDA receptor antagonists.
In the conantokins, the significance of the post-translational 
modification can readily be demonstrated: these peptides are 
inactive in analogs without -y-carboxylation of glutamate resi­
dues. Incomplete -y-carboxylation of blood-clotting factors re­
sults in poor coagulation. I t has been postulated tha t -y-carbox- 
ylation of both the conantokins and of factors of the blood- 
clotting cascade induces a helical conformation in the post- 
translationally modified regions. This postulated role of 
-y-carboxylation in determining conantokin structure has been 
generally supported by a number of subsequent structural 
studies on various conantokins ( 9—12). -y-Carboxyglutamic acid 
confers the property of Ca2^ binding to the modified protein. In 
the case of the blood-clotting factors, the binding to Ca2+ re­
sults in a conformational change exposing hydrophobic resi­
dues for interaction with membranes (13—17).
The enzymatic reaction in the invertebrate system has re­
cently been shown to have many striking similarities (e.g. a 
requirement for reduced vitamin K and the presence of a -y-car- 
boxylation recognition site on the substrate) to tha t of the 
-y-carboxylation of factors involved in the mammalian blood- 
clotting cascade (18, 19). Despite the clear functional impor­
tance of -y-carboxylation in these two disparate phylogenetic 
systems, -y-carboxylation of glutamate residues has been re-

















garded as a highly specialized post-translational modification. 
In this report, we provide evidence tha t is strongly consistent 
with vitamin K-dependent -y-carboxylation in fact being a much 
more widely distributed biological phenomenon. We demon­
strate by molecular techniques the presence of a vitamin K-de­
pendent -y-carboxylase-related protein that is expressed in the 
fruit fly Drosophila melanogaster, which has a high degree of 
sequence identity with the mammalian enzyme. Similar obser­
vations have recently been reported by Li et al. (20). Although 
the role of -y-carboxylation in Drosophila remains unknown, 
this post-translational modification is present in arthropods, 
suggesting that it is generally distributed in animal systems. 
The strong conservation in sequence of the -y-glutamyl carbox­
ylase in Drosophila and in mammals suggests an important 
functional role for the enzyme, resulting in strong selection for 
sequence conservation.
EXPERIMENTAL PROCEDURES
Materials—Conus textile venom ducts were obtained from Dr. L. J. 
Craz (University of the Philippines). Vitamin K (phytonadione) was 
from Abbott Laboratories, and NaHMCO;. (55 mCi/mmol) was from 
PerkinElmer Life Sciences. Enzymes were purchased from Life Tech­
nologies, Inc. PCR1 reactions were performed in an Air Thermo-Cycler 
(Idaho Techology). Oligonucleotides were synthesized at the peptide 
sequencing facility at the University of Utah.
Preparation o f mllNA—Adult Drosophila (Oregon,) were frozen in 
liquid nitrogen and ground to a fine powder, and total RNA was isolated 
(21). Polyf A j ’ RNA was isolated using a Qiagen Oligotex mRNA kit 
according to the vendor’s instructions. Molecular biology experiments 
were done according to methods described by Sambrook et al. (22).
Sequence A?ialysis—The cDNA sequence of Drosophila y-carboxylase 
was assembled from sequences of PCR products obtained by amplifica­
tion of oligo(dT)- or Q.r primed cDNA using primers shown in Table I. 
The primer combinations used in the PCRs are shown in Table I. 
Primers 1 and 2 correspond to amino acid sequences conserved in 
human, bovine, and rat. Primers 5 and 6 were selected from the Dro­
sophila genomic sequence (Berkeley Drosophila Genome Project, acces­
sion number AC005557). 3'-Sequences of the carboxylase mRNA were 
determined by the technique of rapid amplification of cDNA ends de­
scribed by Frohman (23). The PCR product was cloned into the TA 
cloning vector (Invitrogen), and the nucleic acid sequence was deter­
mined. DNA sequencing was performed using ABI Prism BigDye ter­
minators and cycle sequencing with Taq FS DNA polymerase (Life 
Technologies). The DNA sequence was collected and analyzed on an 
ABI Prism 377 automated DNA sequencer (Applied Biosystems, Foster 
City, CA). To obtain the 5' end of the coding sequences, we selected 
primer 6 from the genomic sequence. This allowed us to characterize a 
transcript with an open reading frame from nucleotides 52 (ATG) to 
2198 (TGA). The sequences have been submitted to GenBank; the 
accession number is AF170280.
Analyses of amino acid homology between human (24), bovine (25), 
ra t (26), and Drosophila y-glutamyl carboxylases were carried out using 
Gap and PileUp programs version 4.0, 1998 (Genetics Computer 
Group).
Northern Blot Analysis—Total RNA was isolated from Drosophila at 
various stages of development. Embryos at 0 —2, 2—4, 4 —8, 12—16, and 
16-24 h of development, larval stages 1-3, pupae, and adult flies were 
used in the experiment. Northern blot analysis was performed using 
reagents provided in the Northern Max kit (Ambion). Nine /iig of total 
RNA from each sample were electrophoresed in a 1.5% denaturing 
agarose gel, transferred to a Gene Screen Plus membrane (PerkinElmer 
Life Sciences), and hybridized to [a--2?] UTP-labeled antisense Dro­
sophila y-carboxylase RNA. As a control for loading, a membrane con­
taining identical samples was hybridized to [a-^PJdCTP-labeled Dro­
sophila rp49. RNA molecular weight standards (RNA Millennium) were 
purchased from Ambion. Membranes were exposed to Molecular Dy­
namics (Sunnyvale, CA) Phosphor Screen and scanned. Images were 
analyzed using the NIH Image processing program.
In Situ Hybridization—The spatial distribution of y-glutamyl car­
boxylase RNA was probed by hybridization to whole-mount embryos in
1 The abbreviations used are: PCR, polymerase chain reaction; GC, 
y-carboxylase; BDGP, Berkeley Drosophila Genome Project; y-CRS, 
y-carboxylation recognition signal sequence; GFP, green fluorescent 
protein; S2, Schneider 2.
F ig .  1. V ectors used  fo r the expression  of GFP, y-carboxyla- 
se.GFP, an d  y-carboxylase in  S2 cells.
situ (27). The cDNA was cloned into a dual-promoter (T7 and Sp6) 
vector. Both sense and antisense RNAs were synthesized using the 
appropriate RNA polymerase in the presence of digoxigenin-labeled 
uridine triphosphate. The digoxigenin-labeled RNA was used as probe 
in hybridizations to fixed embryos. The hybridized digoxigenin-labeled 
RNA was detected by incubating the embryos with alkaline phospha­
tase-conjugated anti-digoxigenin antibody and developed using ni- 
troblue tetrzolium and 5-bromo-4-chloro-3-indolyl phosphate.
Transient Expression of y-Glutamyl Carboxylase Activity—DNA con­
taining the coding sequence of Drosophila y-glutamyl carboxylase was 
obtained by PCR amplification of the genomic sequences. The 3' PCR 
primer was designed such that the y-carboxylase (GC) coding sequences 
would be in frame with coding sequences of green fluorescent protein 
(GFP) in the expression plasmid pRmHa-3.GFP (Fig. 1). The y-glutamyl 
carboxylase encoding sequences include the two introns in the genomic 
sequence. pRmHa-3.GFP was constructed by introducing the coding 
sequence of GFP from the pEGFP vector (CLONTECH) into pRmHa-3 
(28). Expression in this plasmid is under the control of the inducible 
metallothionein promoter and carries the alcohol dehydrogenase 
poly(A) addition signal. Drosophila Schneider 2 (S2) cells were trans­
fected with pRmHa-3.GC.GFP DNA using CellFECTIN (Life Technol­
ogies). 24 h after transfection cells were induced with 0.7 mM CuS04. 
48 h after induction 50% of the cells expressed GFP as judged by 
fluorescent microscopy. The results also indicated that the introns were 
properly processed, and a continuous reading frame was present in the 
cloned GC. pRmHa-3.GC.GFP was modified to introduce a stop codon at 
the end of the GC coding sequences and to delete the GFP coding 
sequences. The modified plasmid pRmHa-3.GC* was transfected into 
S2 cells. The cells were induced with 0.7 mM CuS04 and harvested 48 h 
after induction. Cells were washed twice with phosphate-buffered sa­
line and resuspended in buffer containing 25 mM 4-morpholinepropane- 
sulfonic acid, pH 7.0, 0.5 M NaCl, 0.2% 3-[(3-cholamidopropyl)dimenth- 
ylammonioj-l-propanesulfonic acid/phosphatidyl choline, 2 mM EDTA,
2 mM dithiothreitol, 0.2 ftg/ml leupeptin, 0.8 j^g/ml pepstatin, and 0.04 
mg/ml phenylmethylsulfonyl fluoride. The cell suspension was briefly 
sonicated using a Branson 450 sonifier and incubated in ice for 20 min. 
The lysate was assayed for carboxylase activity.
Enzyme Assays—y-Glutamyl carboxylase assays were performed as 
described by Stanley et al. (18). Reactions were done in a total volume 
of 125 i.d containing cell lysate and a final concentration of reagents as 
follows: 25 mM 4-morpholinepropanesulfonic acid, pH 7.4, 0.5 M NaCl, 
0.2% 3-F( 3-cholamidopropyl)dimenthylammonioJ -1-propanesulfonic 
acid, 0.2% phosphatidyl choline, 0.8 M ammonium sulfate, 5 /iiCi of 
NaHMCO;.', 6 mM dithiothreitol, 222 /iiM reduced vitamin K, and 1.2 mM 
of a model substrate, the pentapeptide FLEEL (29). Reaction mixtures 
were incubated at 25 °C for 120 min and were quenched by addition of 
75 /ill of 1 N NaOH. The quenched reaction mixture (160 /.d) was 
transferred to 1 ml of 5% trichloroacetic acid and boiled to remove 
unincorporated MC 02. After cooling, 5 ml of Ecolite (PerkinElmer Life 
Sciences) was added, and the MC 02 incorporated was determined in a 
Beckman LS 9800 counter.
RESULTS
Characterization o f a Putative Drosophila y-Carboxylase 
mRNA Sequence—Poly(A)^ RNA from adult Drosophila was 
used as template for the reverse transcription of cDNA using 
an oligo(dT) primer. An initial segment of cDNA was amplified 
and sequenced using -y-carboxylase primers encoding amino 
acid sequences highly conserved between Drosophila sequences 
from the Berkeley Drosophila Genome Project (BDGP) and all 
mammalian enzymes; the 5 '-oligonucleotide primer (primer 1; 
Table D corresponded to amino acids 395-402, YGYSWDMM, 
and the 3'-primer (primer 2; Table D corresponded to amino 
acids 465-471, IYFDIWC (the amino acid positions correspond 
to human -y-glutamyl carboxylase sequence). The PCR product 








y-G lutam yl Carboxylase in Drosophila 7771
T a b l e  I
Primers used in PCR to identify Drosophila y-glutamvl carboxylase 







5 567-587 GTGGAATAAC CA CA GCTATCT
6 2-22 TGCAAAGGACGTGTTCTTTCG
7 2510-2419 ATCAGTm'ATCACCCATAC











sequence obtained was identical to a DNA sequence in the 
Drosophila genome (BDGP, accession number AC005557).
We carried out further PCR analysis of the cDNA using the 
primers indicated schematically in Table I and Fig. 2A. The 
3'-end of the transcript to the poly(A) addition site was deter­
mined using 3'-rapid amplification of cDNA ends. Polyadenyl- 
ation takes place 20 bases downstream of a consensus Poly(A) 
signal, AATAAA. The remainder of the cDNA was character­
ized by PCR amplification using primers shown in Table I; PCR 
products were cloned, and overlapping sequences were com­
bined to yield the cDNA shown schematically in Fig. 2A.
The cDNA sequence encodes an open reading frame of 670 
amino acids. Examination of the genomic sequence revealed 
two notable differences from the cDNA. First, there are two 
short introns. A schematic comparison of the genomic and 
cDNA, shown in Fig. 2B, illustrates the position of these in­
trons. The nucleic acid sequences at the splice junction are 
shown in Fig. 2C. Second, an as yet uncharacterized processing 
event removes 6 nucleotides from the cDNA (Fig. 2D).
The locations of the two introns are conserved between Dro­
sophila and mammals. As is generally found when comparing 
Drosophila with mammalian introns (30), the Drosophila in­
trons are significantly shorter (for intron I, 58 versus 2204 
nucleotides; for intron II, 72 versus 646 nucleotides). Compar­
ison of the amino acid sequences flanking Drosophila intron II 
and human intron VII is shown in Fig. 2E. There are a total of 
14 introns in both the ra t (26) and the human -y-carboxylase 
genes (31); therefore, Drosophila has both fewer and shorter 
introns compared with the mammalian gene. Fig. 3A shows a 
schematic of amino acid homology between human and Dro­
sophila -y-carboxylase.
The surprising finding from the sequencing described above 
is that an uncharacterized mechanism of RNA processing re­
sults in the deletion of 6 nucleotides that would have been 
present if the DNA were faithfully transcribed. The deletion 
does not change the amino acid homology to the mammalian 
enzyme at this site. This region of cDNA was sequenced at least 
three times as parts of PCR amplification products synthesized 
by different primer pairs. To confirm the genomic sequence of 
our strain, we directly sequenced the genomic DNA from the 
Drosophila strain that was the source of our cDNA. It was 
identical to that from BDGP, which confirmed that the deletion 
of 6 nucleotides was real and not an artifact of strain differ­
ences or cloning or sequencing errors.
With regard to the protein length, the alignment in Fig. 3B 
shows that although the Drosophila enzyme has 17 additional 
amino acids at the N terminus compared with the mammalian 
enzymes, it is significantly shorter at the C-terminal end. All of 
the mammalian enzymes are longer (758 versus 670 amino 
acids). A recent deletion analysis (32) of the bovine enzyme 
suggests that small deletions at the C terminus may be toler­
ated by the wild-type mammalian enzyme. Interestingly, a
Fig. 2. A, schematic of PCR products. Coordinates refer to the 
genomic sequence. Positions of initiation and termination codons, in­
trons, processing site {DELETE), and Poly(A) addition signals are 
shown. B, schematic comparison of genomic and cDNA maps of Dro­
sophila y-carboxylase. C', nucleic acid and amino acid sequences at the 
splice junctions of Drosophila introns I and II. D, cDNA sequences at 
the processing site (DELETE). E, comparison of amino acid sequences 
flanking Drosophila intron II and human intron VII. Amino acids at the 
splice junction are shown in bold.
deletion that resulted in a bovine enzyme that was 676 amino 
acids in length had lower enzymatic activity (15-fold lower with 
respect to y-carboxylation and 400-fold lower than for vitamin 
K epoxidation). It remains to be determined whether other 
Drosophila subunits are necessary to compensate for the 
shorter length of the Drosophila open reading frame.
Northern Blot Analysis—Fig. 4 shows the results of Northern 
blot analysis. Drosophila y-glutamyl carboxylase mRNA is 
--2.7 kb in size (Fig. 4A) and is predominantly expressed in 
12^24-h embryos (Fig. 4B). (However, the more sensitive in situ 
hybridization experiments presented below reveal the presence 
of carboxylase mRNA throughout embryogenesis.) Ribosomal 

































Identity 27% 50% 38% 41% 51% 42% 25% 
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Human 713 LEQLAQEVTYANLRPFEAVGELNPSNTDSSHSNPPESNPDPVHSEF 
Dros .....................................................................................
F ig. 3. A, schematic of amino acid homology between hum an and the 
Drosophila y-glutamyl carboxylase. The two proteins are strongly ho­
mologous over the entire length of the  predicted Drosophila open read­
ing frame. B, protein sequence homology between hum an and Drosoph­
ila vitam in K-dependent carboxylases. Sequences in black boxes 
indicate identical residues; those in gray boxes are homologous resi­
dues. Dots indicate gaps.
(Fig. 4C). Although similar amounts of rp49 mRNA were pres­
ent in the samples from embryos at different developmental 
stages (0-24 h), there was less RNA in larvae, pupae, and 
adult. The reduced level of rp49 mRNA observed at later stages 
is a reflection of reduced synthesis a t these developmental 
stages (33, 34). From densitometric measurements using the 
NIH Image analysis program, we determined the amount of 
-y-carboxylase RNA present relative to rp49 RNA. Normalized 
to rp49 RNA, we estimate that there is at least three times as 
much -y-carboxylase RNA in late stage embryos (16-24 h) rel­
ative to that in adults.
Spatial Expression of y-Carboxylase—When embryos were 
examined to identify the sites of expression of y-glutamyl car­
boxylase, ubiquitous expression of -y-carboxylase RNA was ob­
served throughout embryogenesis. Only antisense transcript
probes cross-hybridized to embryonic mRNAs in situ (Fig. 5, B 
and D). No hybridization-positive embryos were observed when 
sense transcripts were used as probes (Fig. 5, A  and C).
Assays for y-Carboxylase Activity—Lysates of S2 cells trans­
fected with DNA encoding the putative y-glutamyl carboxylase 
were assayed for carboxylase activity. Table II demonstrates 
that S2 cells transfected with pRmHa-3.GC* expresses vitamin 
K-dependent -y-carboxylase activity that is not present in mock- 
transfected cells or cells transfected with pRmHa-3.GFP (data 
not shown).
Substrate Specificity o f y-Carboxylation—Endogenous sub­
strates of both the mammalian (35) and Conus y-glutamyl 
carboxylases contain a -y-carboxylation recognition signal (y- 
CRS) in the propeptide region (19, 36). The presence of a -y-CRS 
at the amino terminus of a substrate greatly enhances the 
efficiency of carboxylation. We have previously identified the 
-y-CRS of a -y-carboxylated Conus peptide, conantokin-G (19). A 
peptide containing proconantokin-G sequences (—20 to +5, 
“GKDRLTQMKRILKQRGNKAR ^G E E E L ^Y ) referred to 
as —20Y in the text below, is efficiently carboxylated by Conus 
carboxylase (19). We determined the carboxylation of both 
FLEEL and —20Y by Conus and Drosophila -y-glutamyl car­
boxylases. The ratio of 14C 02 incorporated in the two sub­
strates (—20Y/FLEEL) by the Conus enzyme was 4, whereas 
that for the Drosophila enzyme was 0.26.
DISCUSSION
In this work, we have characterized a cDNA clone derived 
from adult D. melanogaster mRNA that encodes a protein with 
-y-glutamyl carboxylase activity. The open reading frame is 
homologous to the mammalian -y-glutamyl carboxylase 
throughout its length of 670 amino acids; the degree of se­
quence identity is strikingly high (39% identity and 55% ho­
mology) and comparable with the subset of enzymes highly 
conserved between Drosophila and mammals. One unexpected 
result when comparing the putative genomic DNA sequence 
with the cDNA is that there is an apparent small deletion in 
the cDNA sequence, suggesting that RNA processing of the 
Drosophila -y-glutamyl carboxylase mRNA occurs.
Northern blot analysis indicates that the putative Drosoph­
ila -y-glutamyl carboxylase mRNA is —2.7 kb in size. This is 
-350  nucleotides longer than the open reading frame and 
3'-untranslated region previously characterized from cDNA. 
Because a single RNA isoform is observed, and the 3 '-end of the 
RNA determined by cDNA analysis is unique, the additional 
350 nucleotides represent the length of the poly(A) tail together 
with the 5'-untranslated region. In situ hybridization reveals 
the ubiquitous presence of carboxylase RNA throughout em­
bryogenesis. By reverse transcription-PCR analysis, Li et al. 
(20) have also reported similar observations. In early embryos 
(0-2 h) it is probably of maternal origin, whereas in later 
embryos (2-12 h), there is considerable contribution from em­
bryonic synthesis as suggested by the kinetics of RNA synthe­
sis. In this regard, carboxylase mRNA expression has been 
demonstrated in neuronal and skeletal tissue of postimplanta­
tion ra t embryos during early organogenesis (26).
The discovery that a -y-carboxylase is expressed in Drosoph­
ila opens the door to genetic analysis of vitamin K-dependent 
-y-carboxylation in this model system. The availability of the 
Drosophila -y-glutamyl carboxylase sequence already provides 
significant structure-function information. Some segments are 
clearly much more highly conserved when the Drosophila se­
quence is compared with that of mammalian enzymes; presum­
ably, these are domains of the enzyme most critical for func­
tion. Among the most noteworthy, mammalian and Drosophila 
sequences corresponding to amino acids 385-404 in the Dro­

















Fig. 5. U biquitous tran sc rip tio n  of y-carboxylase in  D rosoph­
ila  em bryos. In situ hybridization to stage 5 (A and B) and 16 (C and 
D) whole-mount embryos with digoxigenin labeled strand-specific 
probes is shown. Ubiquitous gene expression is visible when the an ti­
sense s trand  is used as probe (B and D) but not when the  sense strand 
is used (A and C).
T able II
Carboxylase activity in transfected Drosophila S2 cells
Enzyme1’1 14C02incorporated
Fig. 4. N o rth e rn  b lo t analysis. A. total RNA from Drosophila embryos (0 -24  h) probed with 32P-labeled antisense y-carboxylase RNA. 
Molecular weight standards represent ethidium  bromide-stained RNA Millennium m arkers (Ambion). B and C'. analysis of developmental 
expression of y-carboxylase (B) and rp49 (C) RNAs. Lanes containing RNA from embryos a t 0 -2 . 2 -4 , 4 -8 .  12-16. and 16-24  h  of development, 
larval stages 1-3. pupae, and adult flies are indicated (the lane between 4-8 -h  and 12-16-h  embryo samples is blank).
Heterologous y-CRS sequences are not or are poorly recognized 
by the y-glutamyl carboxylases. y-CRS containing Conus substrate, 
proconantokin G, is poorly carboxylated by the bovine enzyme, 
whereas a peptide, factor IX-18-41, which consists of the propep­
tide and all normally carboxylated residues of the vitamin Inde­
pendent clotting protein factor IX, is not carboxylated by the Conus 
enzyme (18). The poor carboxylation of -20Y by the Drosophila 
enzyme further strengthens the suggestion that the enzymes have 
evolved to recognize their cognate y-CRSs. This is also supported by 
the observation of Li et al. (20), who found that the propeptide of 
human blood coagulation factor IX did not stimulate carboxylation 
by the Drosophila enzyme. Because the Drosophila and human 
y-glutamyl carboxylases share considerable sequence homology, it 
should be possible to identify substrate binding domains by study­
ing carboxylation using chimeric enzymes.
Because y-carboxylated molecules may serve as signals for 
growth and differentiation, differential regulation of y-carbox- 
ylation may operate at multiple levels during development. 
Control may be at the level of synthesis of -y-carboxylase mRNA 
or its translation, or both. Although mRNA may be present, 
enzyme activity may not be obvious. Future experiments will 
be aimed at determining possible differences among levels of 
mRNA, expressed protein, and activity by immunological 
methods (for protein) and y-carboxylase assay (for activity).
y-Carboxyglutamate-containing proteins isolated to date are 
extracellular proteins. y-Carboxyglutamate interacts with 
Ca2+, induces a conformational change in the protein, and 
facilitates binding to membrane phospholipids. A number of 
y-carboxyglutamate-containing vitamin K-dependent proteins 
(thrombin, factor Xa, protein S, and Gas6) are ligands for cell 
surface receptors. Interaction with the receptors induces cellu­
lar proliferative responses (39, 40). In Drosophila, high levels of 
y-carboxylase RNA are detected in late stage embryos. During 
this period, a variety of developmental and morphogenetic 
events occur, among them cuticle deposition and central nerv­
ous system, peripheral nervous system, and gut differentiation. 
It is conceivable that some of the gene products signaling these 
events are y-carboxylated and serve as ligands for correspond­
ing receptors. The effects of y-carboxylase knockout in flies will 
enable a systematic study of probable targets for this post- 
translational modification.
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